20.500.12556/DiRROS-12898 Advance care planning in patients with advanced cancer : a 6-country, cluster-randomised clinical trial Background. Advance care planning (ACP) supports individuals to define, discuss, and record goals and preferences for future medical treatment and care. Despite being internationally recommended, randomised clinical trials of ACP in patients with advanced cancer are scarce. Methods and findings. To test the implementation of ACP in patients with advanced cancer, we conducted a cluster-randomised trial in 23 hospitals across Belgium, Denmark, Italy, Netherlands, Slovenia, and United Kingdom in 2015–2018. Patients with advanced lung (stage III/IV) or colorectal (stage IV) cancer, WHO performance status 0–3, and at least 3 months life expectancy were eligible. The ACTION Respecting Choices ACP intervention as offered to patients in the intervention arm included scripted ACP conversations between patients, family members, and certified facilitators; standardised leaflets; and standardised advance directives. Control patients received care as usual. Main outcome measures were quality of life (operationalised as European Organisation for Research and Treatment of Cancer [EORTC] emotional functioning) and symptoms. Secondary outcomes were coping, patient satisfaction, shared decision-making, patient involvement in decision-making, inclusion of advance directives (ADs) in hospital files, and use of hospital care. In all, 1,117 patients were included (442 intervention; 675 control), and 809 (72%) completed the 12-week questionnaire. Patients’ age ranged from 18 to 91 years, with a mean of 66; 39% were female. The mean number of ACP conversations per patient was 1.3. Fidelity was 86%. Sixteen percent of patients found ACP conversations distressing. Mean change in patients’ quality of life did not differ between intervention and control groups (T-score −1.8 versus −0.8, p = 0.59), nor did changes in symptoms, coping, patient satisfaction, and shared decision-making. Specialist palliative care (37% versus 27%, p = 0.002) and AD inclusion in hospital files (10% versus 3%, p < 0.001) were more likely in the intervention group. A key limitation of the study is that recruitment rates were lower in intervention than in control hospitals. Conclusions. Our results show that quality of life effects were not different between patients who had ACP conversations and those who received usual care. The increased use of specialist palliative care and AD inclusion in hospital files of intervention patients is meaningful and requires further study. Our findings suggest that alternative approaches to support patient-centred end-of-life care in this population are needed. advanced care planning medical treatment advanced cancer palliative care vnaprejšnje načrtovanje oskrbe napredovali rak paliativna nega zdravljenje true false true Public Library of Science Angleški jezik Ni določen © 2020 Korfage et al. Neznano 2020-12-14 09:54:23 2020-12-14 09:54:23 2022-08-19 03:35:33 0000-00-00 00:00:00 2020 0 ZDA 0 Nasl. z nasl. zaslona; Opis vira z dne 20. 11. 2020; Soavtorice iz Slovenije: Branka Červ, Hana Kodba-Čeh, Urška Lunder, Alenka Mimić, Polona Ozbič, Anja Simonič; str. 1-16 no. 11 Vol. 17 2020 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616 1549-1676 10.1371/journal.pmed.1003422 38458371 2944020 RAZ_Korfage_Ida_Joanna_i2020.pdf RAZ_Korfage_Ida_Joanna_i2020.pdf 1 6F6F885E154016DB989E75E8907A632B f74d68523774b71a26becd625fd04a404870f4529effeed75cc96b3874f0d24e 84ce4d5a-17b6-11ed-b6b8-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=17156 RAZ_Korfage_Ida_Joanna_i2020.pdf RAZ_Korfage_Ida_Joanna_i2020.pdf 1 ED0EAA1A09EC15B120E28CD79FA3045F 3900fd8e661ffd4c81de56fd4e3cb48ad98053bbe19f63217a0876f0f5f80174 84bb45e7-17b6-11ed-b6b8-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=17154 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003208 1 https://dirros.openscience.si/Dokument.php?lang=slv&id=15867 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0